Literature DB >> 26108893

Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation.

Megan M Weivoda1, Ming Ruan1, Larry Pederson1, Christine Hachfeld1, Rachel A Davey2, Jeffrey D Zajac2, Jennifer J Westendorf3, Sundeep Khosla1, Merry Jo Oursler1.   

Abstract

Osteoblast-mediated bone formation is coupled to osteoclast-mediated bone resorption. These processes become uncoupled with age, leading to increased risk for debilitating fractures. Therefore, understanding how osteoblasts are recruited to sites of resorption is vital to treating age-related <span class="Disease">bone loss. Osteoclasts release and activate TGF-β from the bone matrix. Here we show that osteoclast-specific inhibition of TGF-β receptor signaling in mice results in osteopenia due to reduced osteoblast numbers with no significant impact on osteoclast numbers or activity. TGF-β induced osteoclast expression of Wnt1, a protein crucial to normal bone formation, and this response was blocked by impaired TGF-β receptor signaling. Osteoclasts in aged murine bones had lower TGF-β signaling and Wnt1 expression in vivo. Ex vivo stimulation of osteoclasts derived from young or old mouse bone marrow macrophages showed no difference in TGF-β-induced Wnt1 expression. However, young osteoclasts expressed reduced Wnt1 when cultured on aged mouse bone chips compared to young mouse bone chips, consistent with decreased skeletal TGF-β availability with age. Therefore, osteoclast responses to TGF-β are essential for coupling bone resorption to bone formation, and modulating this pathway may provide opportunities to treat age-related bone loss.
© 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE REMODELING; COUPLING; OSTEOCLAST; TGF-β; WNT1

Mesh:

Substances:

Year:  2015        PMID: 26108893      PMCID: PMC4758668          DOI: 10.1002/jbmr.2586

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  50 in total

1.  TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.

Authors:  Anne Gingery; Elizabeth W Bradley; Larry Pederson; Ming Ruan; Nikki J Horwood; Merry Jo Oursler
Journal:  Exp Cell Res       Date:  2008-06-13       Impact factor: 3.905

2.  Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling.

Authors:  R Hattner; B N Epker; H M Frost
Journal:  Nature       Date:  1965-05-01       Impact factor: 49.962

3.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.

Authors:  J Pfeilschifter; G R Mundy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Osteoclast synthesis and secretion and activation of latent transforming growth factor beta.

Authors:  M J Oursler
Journal:  J Bone Miner Res       Date:  1994-04       Impact factor: 6.741

5.  Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging.

Authors:  V Nicolas; A Prewett; P Bettica; S Mohan; R D Finkelman; D J Baylink; J R Farley
Journal:  J Clin Endocrinol Metab       Date:  1994-05       Impact factor: 5.958

6.  Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors.

Authors:  Kuniaki Ota; Patrick Quint; Megan M Weivoda; Ming Ruan; Larry Pederson; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  Bone       Date:  2013-07-25       Impact factor: 4.398

7.  Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.

Authors:  Matteo M Guerrini; Cristina Sobacchi; Barbara Cassani; Mario Abinun; Sara S Kilic; Alessandra Pangrazio; Daniele Moratto; Evelina Mazzolari; Jill Clayton-Smith; Paul Orchard; Fraser P Coxon; Miep H Helfrich; Julie C Crockett; David Mellis; Ashok Vellodi; Ilhan Tezcan; Luigi D Notarangelo; Michael J Rogers; Paolo Vezzoni; Anna Villa; Annalisa Frattini
Journal:  Am J Hum Genet       Date:  2008-07       Impact factor: 11.025

8.  Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss.

Authors:  P D Delmas; D Stenner; H W Wahner; K G Mann; B L Riggs
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

9.  Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans.

Authors:  Matthew M Roforth; Koji Fujita; Ulrike I McGregor; Salman Kirmani; Louise K McCready; James M Peterson; Matthew T Drake; David G Monroe; Sundeep Khosla
Journal:  Bone       Date:  2013-10-29       Impact factor: 4.398

10.  Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling.

Authors:  Maria Arantzazu Sanchez-Fernandez; Anne Gallois; Thilo Riedl; Pierre Jurdic; Bernard Hoflack
Journal:  PLoS One       Date:  2008-10-27       Impact factor: 3.240

View more
  24 in total

1.  RIP140 in monocytes/macrophages regulates osteoclast differentiation and bone homeostasis.

Authors:  Bomi Lee; Urszula T Iwaniec; Russell T Turner; Yi-Wei Lin; Bart L Clarke; Anne Gingery; Li-Na Wei
Journal:  JCI Insight       Date:  2017-04-06

Review 2.  Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.

Authors:  Eben G Estell; Clifford J Rosen
Journal:  Nat Rev Endocrinol       Date:  2020-11-04       Impact factor: 43.330

Review 3.  Osteoclast differentiation by RANKL and OPG signaling pathways.

Authors:  Nobuyuki Udagawa; Masanori Koide; Midori Nakamura; Yuko Nakamichi; Teruhito Yamashita; Shunsuke Uehara; Yasuhiro Kobayashi; Yuriko Furuya; Hisataka Yasuda; Chie Fukuda; Eisuke Tsuda
Journal:  J Bone Miner Metab       Date:  2020-10-20       Impact factor: 2.626

Review 4.  Novel insights into the coupling of osteoclasts and resorption to bone formation.

Authors:  Margaret M Durdan; Ruth D Azaria; Megan M Weivoda
Journal:  Semin Cell Dev Biol       Date:  2021-10-30       Impact factor: 7.727

Review 5.  Bone remodeling: an operational process ensuring survival and bone mechanical competence.

Authors:  Simona Bolamperti; Isabella Villa; Alessandro Rubinacci
Journal:  Bone Res       Date:  2022-07-18       Impact factor: 13.362

6.  Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.

Authors:  Lomeli R Carpio; Elizabeth W Bradley; Meghan E McGee-Lawrence; Megan M Weivoda; Daniel D Poston; Amel Dudakovic; Ming Xu; Tamar Tchkonia; James L Kirkland; Andre J van Wijnen; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Sci Signal       Date:  2016-08-09       Impact factor: 8.192

Review 7.  Bone metastasis: the importance of the neighbourhood.

Authors:  Peter I Croucher; Michelle M McDonald; T John Martin
Journal:  Nat Rev Cancer       Date:  2016-05-25       Impact factor: 60.716

8.  TGFβ Regulation of Perilacunar/Canalicular Remodeling Is Sexually Dimorphic.

Authors:  Neha S Dole; Cristal S Yee; Courtney M Mazur; Claire Acevedo; Tamara Alliston
Journal:  J Bone Miner Res       Date:  2020-05-13       Impact factor: 6.390

9.  Smad4 is required to inhibit osteoclastogenesis and maintain bone mass.

Authors:  Mayu Morita; Shigeyuki Yoshida; Ryotaro Iwasaki; Tetsuro Yasui; Yuiko Sato; Tami Kobayashi; Ryuichi Watanabe; Takatsugu Oike; Kana Miyamoto; Masamichi Takami; Keiko Ozato; Chu-Xia Deng; Hiroyuki Aburatani; Sakae Tanaka; Akihiko Yoshimura; Yoshiaki Toyama; Morio Matsumoto; Masaya Nakamura; Hiromasa Kawana; Taneaki Nakagawa; Takeshi Miyamoto
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

10.  The Effect of Long-Term Exercise on the Production of Osteoclastogenic and Antiosteoclastogenic Cytokines by Peripheral Blood Mononuclear Cells and on Serum Markers of Bone Metabolism.

Authors:  J Kelly Smith; Rhesa Dykes; David S Chi
Journal:  J Osteoporos       Date:  2016-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.